Research Studies
The Below the Belt events supports ideas that are not yet fully fledged clinical trials but might evolve into them. Without the funds raised through the Below the events it would not be possible to grow ideas for future work.
The Below the Belt Research Fund has supported many members in the development of investigator-initiated studies. Listed below are the many Below the Belt Research Fund recipient studies.
BELOW THE BELT AWARD
2024
Weranja Ranasinghe
Evaluating the BCG-R5 immune marker to define BCG response in high-risk non-muscle invasive bladder cancer and personalise intravesical therapy
BELOW THE BELT AWARD
2024
Vinod Subhash
Extracellular vesicle Informed Therapeutics in Prostate Cancer
BELOW THE BELT AWARD
2024
Dr Cynthia Hawks
Gemcitabine-Docetaxel Intravesical Instillation SynChrOnously – a
Phase I study (G-DISCO)
BELOW THE BELT AWARD
2024
Arti Raghubar
Defining the kidney cancer microenvironment
BELOW THE BELT AWARD
2023
James Buteau
Implementing and Improving Access for the Predictive and Prognostic Biomarkers of Baseline PSMA and FDG PET of Patients with Prostate Adenocarcinoma Evaluated in TheraP Study (ANZUP 1603)
BELOW THE BELT AWARD
2023
Niall Corcoran
Australian Penile Cancer Registry
BELOW THE BELT AWARD
2023
Craig Gedye
Are ‘Dark Dimers’ Associated with Immunotherapy Benefit in Kidney Cancer?
BELOW THE BELT AWARD
2023
Ramesh Shanmugasundaram
The MBC Trial – Assessment of the diagnostic utility of multi-parametric MRI Before Cystoscopy in patients presenting with a bladder mass: a multicentre prospective study
BELOW THE BELT AWARD
2022
Chun Loo Gan
PREDICTing treatment response to first-line immunotherapy-based combinations with PSMA and FDG PET in advanced Renal Cell Carcinoma
BELOW THE BELT AWARD
2022
Louise Emmett
The RE-SPECT project: Development of interim response biomarkers in Lu PSMA therapy.
BELOW THE BELT AWARD
2022
Shomik Sengupta
Non-muscle invasive bladder cancer registry
BELOW THE BELT AWARD
2022
Weranja Ranasinghe
Utilising a pro-inflammatory gene signature and immune cell markers to identify non-muscle invasive bladder cancer patients at high risk of intravesical BCG failure.
BELOW THE BELT AWARD
2021
Ciara Conduit
Exploring the activity of pseudoephedrine in treating retrograde ejaculation following retroperitoneal lymph node dissection in survivors of testicular cancer (PREPARE)
BELOW THE BELT AWARD
2021
Joshua Kealey
ACCEPT-U – Australian Multicentre Prospective Registry to Evaluate Practice and Patient Outcomes in Upper Tract Urothelial Carcinoma
BELOW THE BELT AWARD
2021
Megan Crumbaker
A Phase II study of high dose testosterone in combination with carboplatin in men with metastatic castrate-resistant prostate cancer
BELOW THE BELT AWARD
2021
Steve McCombie
Identifying tumour and immune stromal features that correlate with optimal benefit from BCG and Mitomycin: a translational sub-study of patients in the BCGMM Trial
BELOW THE BELT AWARD
2020
Matthew Roberts
De-Intensification of Post ProstatEctomy Radiotherapy (DIPPER) incorporating clinical and imaging-based risk stratification: Part 1 – Pilot study (additional site)
BELOW THE BELT AWARD
2020
Louise Emmett and Michael Hofman
PRIMARY 2: A prospective, multicentre, randomised study of Ga-68 PSMA /CT + mpMRI vs mpMRI alone for prostate cancer diagnosis.
BELOW THE BELT AWARD
2020
Alex Tan
PRIUS MR: Prostate Re-Irradiation Using SABR and MRI Guidance
BELOW THE BELT AWARD
2020
Anis Hamid
MEMENTO: Biomarker discovery in metastatic hormone sensitive prostate cancer (MEtastatic Prostate Cancer MEthylation and Transcriptional biOmarker Study)
BELOW THE BELT AWARD
2020
Andrew Weickhardt
68Ga-PSMA PET as a potential Imaging biomarker post tyrosine kinase inhibition of metastatic clear cell Renal cell Cancer (PIRC) – a pilot study
BELOW THE BELT AWARD
2019
Andrew Moe
SUBDUE – 1 SUB-urothelial DUrvalumab InjEction – 1
BELOW THE BELT AWARD
2019
Ben Tran
CLIMATE: Assessing the Clinical utility of miR-371 as a marker of residual disease in Clinical Stage 1 Testicular Germ Cell Tumour, following orchidectomy
BELOW THE BELT AWARD
2019
Dr Carole Harris
What, where, when and how long? Using PBS data to understand patterns of care and survival in Australian patients treated for metastatic clear cell kidney cancer
BELOW THE BELT AWARD
2019
Associate Professor Craig Gedye
AdapTax: feasibility, acceptability and safety of adaptively dosed docetaxel in men with metastatic castrate-resistant prostate cancer
BELOW THE BELT AWARD
2019
Dr Kate Mahon
Randomised trial of biomarker-driven intermittent docetaxel versus standard-of-care (SOC) docetaxel in metastatic castration-resistant prostate cancer (mCRPC)
BELOW THE BELT AWARD
2019
Professor Shomik Sengupta
Genomic & immunological predictors of response to intravesical therapy
BELOW THE BELT AWARD
2018
Dr Camille Short
Why do men leave active surveillance? A mixed methods investigation examining factors contributing to adherence on active surveillance
BELOW THE BELT AWARD
2018
Dr Ben Smith
Development and piloting of a Question Prompt List (QPL) to aid informed treatment decision making in men diagnosed with localised prostate cancer
BELOW THE BELT AWARD
2018
Professor Shomik Sengupta
Feasibility of water irrigation post TURBT for NMIBC
BELOW THE BELT AWARD
2018
Associate Professor Craig Gedye
EnzAdapt: feasibility, acceptability and safety of adaptive dosing of enzalutamide in men with metastatic castrate-resistant prostate cancer
BELOW THE BELT AWARD
2018
Dr Edmond Kwan and Dr Heidi Fettke
Application of a multi-gene prostate circulating tumour DNA (ctDNA) panel in men with metastatic hormone-sensitive prostate cancer (mHSPC)
BELOW THE BELT AWARD
2018
Associate Professor Haryana Dhillon
Assessing the feasibility, acceptability and impact on practice of electronic patient reported outcome assessment of symptoms in people with Genitourinary cancer: a mixed methods study
BELOW THE BELT AWARD
2018
Dr Mark Stein
A pilot trial of Exendin PET scanning in metastatic castrate resistant prostate cancer
BELOW THE BELT AWARD
2018
Professor Suzanne Chambers
QualTheraP: A nested, multi-perspective longitudinal qualitative study of participants in the TheraP trial
BELOW THE BELT AWARD
2017
Associate Professor Ben Tran
iTestis: Bioinformatics for Testis Cancer
BELOW THE BELT AWARD
2017
Professor Dennis Taaffe
Exercise Medicine Prior to Open Radical Cystectomy: Feasibility and Preliminary Efficacy
BELOW THE BELT AWARD
2017
Professor Dickon Hayne
ANZUP co-operative multi-centre cystectomy database (ACCEPT)
BELOW THE BELT AWARD
2017
Professor Lisa Horvath
Statins in Metastatic Castration-Resistant Prostate Cancer (CRPC)
BELOW THE BELT AWARD
2017
Dr Megan Crumbaker & Professor Anthony Joshua
Bipolar androgen therapy (BAT) in men with metastatic castrate-refractory prostate cancer
BELOW THE BELT AWARD
2017
Dr Camille Short
Delivering personalised and evidence-based exercise support to men with metastatic prostate cancer via the internet – A pilot RCT examining intervention impact on behaviour change and quality of life
Prostate
Startup
Exercise Guide
N/A
Delivering an individualised web-based exercise intervention (ExerciseGuide) to support men with metastatic prostate cancer: A pilot randomised control trial.